Does ALPRAZOLAM Cause Neoplasm malignant? 57 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Neoplasm malignant have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.1% of all adverse event reports for ALPRAZOLAM.
57
Reports of Neoplasm malignant with ALPRAZOLAM
0.1%
of all ALPRAZOLAM reports
10
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm malignant From ALPRAZOLAM?
Of the 57 reports, 10 (17.5%) resulted in death, 6 (10.5%) required hospitalization, and 2 (3.5%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ALPRAZOLAM Alternatives Have Lower Neoplasm malignant Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE